In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Mayo Clinic’s new collaboration with Thermo Fisher and the latest on the Protecting Access to Medicare Act (PAMA). Later, Dr. Pritt welcomes Matt Binnicker, Ph.D., Mayo Clinic Laboratories’ chief scientific officer and a leader in novel diagnostics for viral infections, to explore seasonal virus activity.

• Mayo Clinic and Thermo Fisher collaboration (00:29): Explore how this initiative is turning early biological signals into opportunities for prevention, diagnosis, and treatment.
• PAMA preliminary rates (04:20): Get an overview of CMS's preliminary 2027 Medicare Clinical Laboratory Fee Schedule based on data collected through PAMA.
• Virus update and outlook (08:30): Learn what experts are predicting for seasonal viruses this winter.
• Testing stewardship and innovation (15:43): Discover guidance for seasonal virus testing and how new advances are improving detection.

Resources

• Mayo Clinic News Network: Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear
• CMS: Preliminary Calendar Year (CY) 2027 Medicare Clinical Laboratory Fee Schedule Payment Rates
• Respiratory viruses: Testing for early detection

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.

• Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
• Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
• Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.

Resources

• Survey reveals four strategies for laboratory growth
• Vaccine and immunization guidance from Mayo Clinic
• Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption Webinar
• Bile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrhea
• The right testing for an underrecognized cause of chronic diarrhea

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss advancement in Alzheimer’s testing and practical uses of artificial intelligence (AI) in healthcare. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore the evolving role of data in research and development.

• Innovative Alzheimer’s test gets FDA clearance (00:33): Dr. Morice shares how a strategic collaboration is enabling Mayo Clinic Laboratories to offer a newly FDA-cleared blood test for Alzheimer’s disease for adults with cognitive symptoms as young as 40.
• AI helping diagnose rare diseases (03:37): Dr. Pritt and Dr. Morice reflect on a recent article highlighting how AI is helping clinicians identify rare diseases.
• Data use in research and development (08:16): Dr. Garcia discusses how data, AI, and cross-disciplinary collaboration are advancing research and innovation in laboratory medicine.

Note: Information in this post was accurate at the time of its posting.

Resources

• C2N Diagnostics: FDA clears C2N Diagnostics’ PrecivityAD2® —First Alzheimer’s blood test for adults with cognitive symptoms as young as 40
• Wall Street Journal: AI is helping patients solve medical mysteries
• Answers From the Lab: Digital Advances: What's Next for Clinical Diagnostics?
• Answers From the Lab: Accelerating Research and Development With BioPharma Diagnostics